From October 2010 to February 2011, biotech Clinical Data’s stock doubled, mostly thanks to FDA approval of its novel antidepressant. But also pushing the stock up — and making it likely to perhaps double again — is speculati…
Investors piled into Chinese stocks after news broke that China’s GDP surpassed Japan’s for 2010, making the People’s Republic the world’s second largest economy after the U.S. The Shanghai Composite climbed 2.5% and in Hong Ko…
The market heads into a busy week of economic reports and the end of fourth-quarter earnings season primed for yet more gains. After all, if traders could sustain the rally through 18 days of Egyptian turmoil, a return to keyin…
From a strategy standpoint, there’s some sound reasoning behind CEO Stephen Elop’s thinking: Most likely there’s room for a third player at Apple and Google’s poker table. But Nokia’s new deal with Microsoft will be all about h…
For those who can’t get bank loans, the new business of peer-to-peer lending can be a lifesaver. Internet companies connect people who need cash with folks willing to lend — for a fair profit, of course. Here’s how it works, r…